NasdaqGS - Delayed Quote USD

Intuitive Surgical, Inc. (ISRG)

Compare
436.74 -17.28 (-3.81%)
At close: 4:00 PM EDT
436.96 +0.22 (+0.05%)
After hours: 7:47 PM EDT
Loading Chart for ISRG
DELL
  • Previous Close 454.02
  • Open 453.22
  • Bid 435.75 x 100
  • Ask 436.69 x 100
  • Day's Range 436.20 - 457.07
  • 52 Week Range 254.85 - 468.78
  • Volume 1,797,119
  • Avg. Volume 1,425,336
  • Market Cap (intraday) 161.359B
  • Beta (5Y Monthly) 1.39
  • PE Ratio (TTM) 78.13
  • EPS (TTM) 5.59
  • Earnings Date Oct 17, 2024 - Oct 21, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 468.85

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

www.intuitive.com

13,676

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ISRG

View More

Related Videos: ISRG

Performance Overview: ISRG

Trailing total returns as of 7/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ISRG
29.46%
S&P 500
13.20%

1-Year Return

ISRG
34.98%
S&P 500
18.54%

3-Year Return

ISRG
34.18%
S&P 500
22.38%

5-Year Return

ISRG
141.28%
S&P 500
78.81%

Compare To: ISRG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ISRG

View More

Valuation Measures

Annual
As of 7/24/2024
  • Market Cap

    161.36B

  • Enterprise Value

    156.60B

  • Trailing P/E

    78.02

  • Forward P/E

    72.46

  • PEG Ratio (5yr expected)

    4.71

  • Price/Sales (ttm)

    21.56

  • Price/Book (mrq)

    10.97

  • Enterprise Value/Revenue

    20.68

  • Enterprise Value/EBITDA

    65.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    27.65%

  • Return on Assets (ttm)

    7.99%

  • Return on Equity (ttm)

    15.77%

  • Revenue (ttm)

    7.57B

  • Net Income Avi to Common (ttm)

    2.09B

  • Diluted EPS (ttm)

    5.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.76B

  • Total Debt/Equity (mrq)

    1.91%

  • Levered Free Cash Flow (ttm)

    372.34M

Research Analysis: ISRG

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

380.00 Low
468.85 Average
436.74 Current
525.00 High
 

Company Insights: ISRG

Research Reports: ISRG

View More
  • Raising target and EPS estimates

    Intuitive Surgical designs, manufactures, and markets da Vinci robotic surgical systems and related instruments and accessories in the U.S. and internationally. The da Vinci system enables surgeons to perform a wide range of surgical procedures with shorter recovery periods and higher patient comfort. ISRG was founded in 1995 and is headquartered in Sunnyvale, California.

    Rating
    Price Target
     
  • Earnings news is the big driver today. All the action is mostly in individual

    Earnings news is the big driver today. All the action is mostly in individual stocks reacting to whether last quarter was positive or negative, plus any intel on outlook. The major indices are muted though small caps are showing momentum higher.

     
  • Intuitive Earnings: Procedure Growth in the US Continues to Impress

    Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.

    Rating
    Price Target
     
  • Intuitive Earnings: Results in Line; Placements of New Platform Commence

    Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.

    Rating
    Price Target
     

People Also Watch